Bio-Rad Laboratories (BIO) Depreciation & Amortization (CF) (2009 - 2017)
Bio-Rad Laboratories' (BIO) quarterly Depreciation & Amortization (CF) came in at $35.4 million in Q3 2017, down 8.12% year-on-year from $38.5 million in Q3 2016, and down 4.49% on a QoQ basis from $37.0 million in Q2 2017.
Bio-Rad Laboratories (BIO) Depreciation & Amortization (CF) (2009 - 2017) Analysis & Trends
Bio-Rad Laboratories (BIO) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $35.4 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 35.36 Mn |
| Sep 30, 2017 | 35.36 Mn |
| Jun 30, 2017 | 37.03 Mn |
| Jun 30, 2017 | 37.03 Mn |
| Mar 31, 2017 | 33.66 Mn |
| Mar 31, 2017 | 33.66 Mn |
| Sep 30, 2016 | 38.49 Mn |
| Sep 30, 2016 | 38.49 Mn |
| Jun 30, 2016 | 37.58 Mn |
| Jun 30, 2016 | 37.58 Mn |
| Mar 31, 2016 | 34.09 Mn |
| Mar 31, 2016 | 34.09 Mn |
| Sep 30, 2015 | 33.56 Mn |
| Sep 30, 2015 | 33.56 Mn |
| Jun 30, 2015 | 32.13 Mn |
| Jun 30, 2015 | 32.13 Mn |
| Mar 31, 2015 | 32.28 Mn |
| Mar 31, 2015 | 32.28 Mn |
| Sep 30, 2014 | 37.12 Mn |
| Sep 30, 2014 | 37.12 Mn |